Psychoneuroendocrinology
Volume 34, Issue 3 , Pages 367-381, April 2009

Chronic fluoxetine treatment increases expression of synaptic proteins in the hippocampus of the ovariectomized rat: Role of BDNF signalling

  • Olivia F. O’Leary

      Affiliations

    • Corresponding Author InformationCorresponding authors at: Neuroscience Centre, University of Helsinki, P.O. Box 56 (Viikinkaari 4), 00014 Helsinki, Finland. Tel.: +358 9 191 57626; fax: +358 9 191 57620.
  • ,
  • Xuefei Wu
  • ,
  • Eero Castren

      Affiliations

    • Corresponding Author InformationCorresponding authors at: Neuroscience Centre, University of Helsinki, P.O. Box 56 (Viikinkaari 4), 00014 Helsinki, Finland. Tel.: +358 9 191 57626; fax: +358 9 191 57620.

Neuroscience Centre, University of Helsinki, Finland

Received 4 June 2008; received in revised form 23 September 2008; accepted 24 September 2008.

Summary 

Antidepressant drugs have been suggested to regulate synaptic transmission and structure. We hypothesised that antidepressant-induced changes in synapses and their associated proteins might become more apparent if they were measured under conditions of reduced synapse density. Therefore, in the present study, we examined whether chronic treatment with the antidepressant, fluoxetine alters expression of synaptic proteins in the hippocampus of rodents that underwent ovariectomy, a procedure which reportedly decreases synapse density in the CA1 region of the rat hippocampus. Using Western blotting, we measured changes in hippocampal expression of proteins associated with synapse structure, strength and activity namely, postsynaptic density protein 95 (PSD-95), the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA-R) subunit GluR1 and phosphosynapsin (Ser9), respectively. We found that fluoxetine treatment increased expression of phosphosynapsin, PSD-95 and synaptic GluR1 (but not total GluR1) in the hippocampus of ovariectomized but not sham rats.

Since BDNF and signalling at its receptor, TrkB, can mediate behavioural responses to antidepressants and induce neuronal plasticity, we investigated the contribution of TrkB signalling to fluoxetine-induced changes in synaptic protein expression by using a transgenic mouse model overexpressing a truncated form of the TrkB receptor (TrkB.T1). Fluoxetine produced a small but significant increase in hippocampal PSD-95 in ovariectomized wildtype mice but not in ovariectomized TrkB.T1 mice or sham mice. In contrast to rats, fluoxetine did not alter expression of synaptic GluR1 and did not reverse ovariectomy-induced decreases in hippocampal phosphosynapsin in either genotype. Taken together, these results suggest that chronic fluoxetine treatment can increase synaptic protein expression in the hippocampus and at least some of these effects require TrkB signalling. Moreover, these effects were only observed in ovariectomized animals, thus suggesting that fluoxetine-induced increases in synaptic protein levels might only occur or become detectable when hippocampal synaptic connectivity is perturbed.

Keywords: Antidepressant, Plasticity, PSD-95, AMPA, Ovariectomy, BDNF

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0306-4530(08)00258-8

doi:10.1016/j.psyneuen.2008.09.015

Psychoneuroendocrinology
Volume 34, Issue 3 , Pages 367-381, April 2009